课题基金 / 基金详情

Development of Vaccine againest New Serotype O139 Bengal of Vibrio cholerae

Development of Vaccine againest New Serotype O139 Bengal of Vibrio cholerae
霍乱弧菌O139孟加拉新血清型疫苗的研制
批准号:
07044302
负责人:
TAKEDA Yoshifumi
金额:
$3.33万
依托单位国家:
日本
项目类别:
Grant-in-Aid for international Scientific Research
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996

项目摘要

项目成果

TAKEDA Yoshifumi的其他基金

相似基金

相关文献

中文摘要
翻译
O139孟加拉型霍乱弧菌是一种新的霍乱弧菌血清型,于1992年在印度首次分离出来,并于1993年上半年在整个印度次大陆蔓延。然而,在1993年下半年,霍乱弧菌占主导地位,1994年和1995年,从印度次大陆霍乱患者身上分离出的大多数霍乱弧菌是霍乱弧菌。1996年秋,我们在印度加尔各答目睹了O139霍乱弧菌的死灰复燃。霍乱弧菌血清型变化的流行病学调查为开发O139霍乱弧菌候选疫苗提供了重要信息。对O1型霍乱弧菌和O139型霍乱弧菌的遗传分析表明,1994-1995年分离的O1型霍乱弧菌与O139型霍乱弧菌的RFLP相似,但与1993年O139型霍乱弧菌出现前分离的O1型霍乱弧菌的RFLP不一致。
英文摘要
Vibrio cholerae O139 Bengal, a new serotype of cholerae vibrio, was first isolated in 1992 in India and it spread all over the Indian subcontinent during the first half of the year 1993. However, during the second half of 1993, V.cholerae O1 dominated and, in 1994 and 1995, most of V.cholerae isolated from cholera patients in the Indian subcontinent were V.cholerae O1. In the fall of 1996, we witnessed the resurgence of V.cholerae O139 Bengalin Calcutta, India.Epidemiological survey of such a change of serotypes of V.cholerae provided an important information to develop a candidate vaccine against V.cholerae O139.Genetic analysis of V.cholerae O1 and O139 showed that strains of V.cholerae O1 isolated during 1994-1995 resembled in their RFLP patterns to those of V.cholerae O139 but not to those of V.cholerae O1 isolated before the emergence of V.cholerae O139 on 1993.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
A.K.Mukhopadhyay: "Temporal shifts in traits of Vibrio cholerae strains isolated from hospitalized patients in Calcutta" Journal of Clinical Microbiology. 34. 2537-2543 (1996)
A.K.Mukhopadhyay:“从加尔各答住院患者中分离出的霍乱弧菌菌株特征的时间变化”《临床微生物学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
A.K.Mukhopadhyay et al.: "Temporal shifts in traits of Vibrio cholerae strains isolated from hospitalized patiants in Calcutta" Journal of Clinical Microbiology. 34. 2537-2543 (1996)
A.K.Mukhopadhyay 等人:“从加尔各答住院患者中分离出的霍乱弧菌菌株特征的时间变化”《临床微生物学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shingo Yamamoto: "Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diar sheagenicity but retain adjnvanticity" Journal of Experimental Medicine. 185. 1-8 (1997)
Shingo Yamamoto:“霍乱毒素 ADP-核糖基转移酶裂口中的突变体缺乏二聚性,但保留了辅助性”《实验医学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shingo Yamamoto: "A nontoxic mutant of clolera toxin elicits Th2-type responses for enhanced mucosal immunity" Proceeding of National Academy of Sciencer,US. (印刷中). (1997)
Shingo Yamamoto:“克罗拉毒素的无毒突变体引发 Th2 型反应,增强粘膜免疫”,美国国家科学院院刊(1997 年出版)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 21 条
    Development of a vaccine against enterohemorrhagic Escherichia coli
    Mechanism of development of diarrhea by enteric bacteria
    Deparment of vaccine for new type of Vibrio cholerae O139 Bengal
    study on diarrbeagenic toxins produced by enteric bacteria
    海外基金